Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (271-280 of 6,083) with videos related to

Pageof 609
Sort By:
The Prostate|September 25, 2004
Ability of PSA-positive circulating macrophages to detect prostate cancerRalf Herwig, Wolfgang Horninger, Peter Rehder, et al.
The Prostate|September 21, 2004
Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined diseaseCarmela Ricciardelli, Catherine S Choong, Grant Buchanan, et al.
The Prostate|June 4, 2004
Prostein expression is highly restricted to normal and malignant prostate tissuesMichael Kalos, Jon Askaa, Bonnie L Hylander, et al.
The Prostate|February 18, 2004
Molecular characterization of the commonly used human androgen receptor expression vector, pSG5-ARIvan V Litvinov, Chawnshang Chang, John T Isaacs
The Prostate|February 18, 2004
Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatographyPing Wu, Ulf-Håkan Stenman, Miikka Pakkala, et al.
The Prostate|February 18, 2004
A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patientsG van Andel, A P Visser, A H Zwinderman, et al.
The Prostate|February 18, 2004
Differential expression of hZnT-4 in human prostate tissuesFrances W J Beck, Ananda S Prasad, Charles E Butler, et al.
The Prostate|February 18, 2004
Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphismsRui Medeiros, André Vasconcelos, Sandra Costa, et al.
The Prostate|February 18, 2004
Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin AAlessandro Sciarra, Giuseppe Voria, Salvatore Monti, et al.
The Prostate|January 25, 2005
Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer developmentHitoshi Ishiguro, Noboru Nakaigawa, Yasuhide Miyoshi, et al.
Pageof 609

Showing results (271-280 of 6,083) with videos related to

Sort By:
Pageof 609
The Prostate|September 25, 2004
Ability of PSA-positive circulating macrophages to detect prostate cancerRalf Herwig, Wolfgang Horninger, Peter Rehder, et al.
The Prostate|September 21, 2004
Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined diseaseCarmela Ricciardelli, Catherine S Choong, Grant Buchanan, et al.
The Prostate|June 4, 2004
Prostein expression is highly restricted to normal and malignant prostate tissuesMichael Kalos, Jon Askaa, Bonnie L Hylander, et al.
The Prostate|February 18, 2004
Molecular characterization of the commonly used human androgen receptor expression vector, pSG5-ARIvan V Litvinov, Chawnshang Chang, John T Isaacs
The Prostate|February 18, 2004
Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatographyPing Wu, Ulf-Håkan Stenman, Miikka Pakkala, et al.
The Prostate|February 18, 2004
A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patientsG van Andel, A P Visser, A H Zwinderman, et al.
The Prostate|February 18, 2004
Differential expression of hZnT-4 in human prostate tissuesFrances W J Beck, Ananda S Prasad, Charles E Butler, et al.
The Prostate|February 18, 2004
Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphismsRui Medeiros, André Vasconcelos, Sandra Costa, et al.
The Prostate|February 18, 2004
Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin AAlessandro Sciarra, Giuseppe Voria, Salvatore Monti, et al.
The Prostate|January 25, 2005
Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer developmentHitoshi Ishiguro, Noboru Nakaigawa, Yasuhide Miyoshi, et al.
Pageof 609